Physician profile
Mina Mikhail
NPI 1336226786
$5,775.99
in general payments reported to CMS, 2019-2025
38 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $669 · 2020: $401 · 2021: $941 · 2022: $1,225 · 2023: $642 · 2024: $870 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,539.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,011.61 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbott Laboratories | $578.61 | 2019-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $443.07 | 2022-2025 | |
| Novo Nordisk INC | $413.59 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $372.44 | 2019-2024 | Verquvo, Belsomra, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $319.38 | 2020-2024 | Jardiance |
| Amgen INC. | $314.59 | 2019-2025 | Repatha, Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $265.85 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $258.20 | 2021-2023 | |
| Lilly USA, LLC | $249.46 | 2019-2024 | Jardiance, Emgality |
| Esperion Therapeutics, INC. | $195.41 | 2021-2025 | Nexletol |
| Glaxosmithkline, LLC. | $192.47 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $153.83 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $138.25 | 2019-2024 | Xarelto |
| Abbvie INC. | $123.72 | 2020-2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Mikhail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.